0
     

Report Added
Report already added
APAC Infusion Pumps Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)), Technology (Traditional, Specialty), Application (Cancer, Diabetes), & End User (Hospital, Home Care) - Fore cast to 2027

APAC Infusion Pumps Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)), Technology (Traditional, Specialty), Application (Cancer, Diabetes), & End User (Hospital, Home Care) - Fore cast to 2027

The infusion pumps market is expected to reach USD 5.7 billion by 2027 from an estimated USD 3.7 billion in 2022, at a CAGR of 9.1%. The growth of this market is majorly driven by the increasing incidence of chronic diseases along with the rapid growth of the geriatric population, increasing adoption of enteral feeding pumps with surge in pre-term births, increasing number of ICU beds in countries with a high prevalence of COVID-19, and the growing volume of surgical procedures performed. Also, the rising demand for ambulatory infusion pumps in homecare settings in developing economies is expected to offer significant opportunities for market growth in the coming years. However, the increasing adoption of refurbished and rental infusion pumps is expected to restrain market growth to a certain extent.

Based on product type, the accessories & consumables segment holds the largest market share during the forecast period.

Based on products, the APAC infusion pumps market has been segmented into accessories & consumables and devices. The accessories & consumables segment accounted for the largest share of the infusion pumps market in 2021. The increasing adoption of infusion pumps for the delivery of medications in a controlled environment and the recurrent use of accessories & consumables are the factors propelling the growth of this market.

Based on infusion pump devices, the volumetric infusion pump accounted for the highest market share during the forecast period.

Based on devices, the APAC infusion pump market is segmented into volumetric infusion pumps, insulin pumps, enteral infusion pumps, ambulatory infusion pumps, syringe infusion pumps, patient-controlled analgesia (PCA) pumps, and implantable infusion pumps. The volumetric infusion pumps segment accounted for the largest share of the infusion pump devices market in 2021. Volumetric infusion pumps are widely used to deliver large volumes of fluid to patients. These pumps are capable of delivering fluids, blood transfusions, and total parental nutrition (TPN) to patients at continuous predetermined medium-to-high flow rates. These devices are useful for almost all areas of healthcare and are widely used for IVs.

Based on application, the diabetes segment is expected to register the highest CAGR during the forecast period.

Based on application, the APAC infusion pumps market is segmented into chemotherapy/oncology, diabetes management, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other applications (includes infectious diseases, autoimmune diseases, and diseases of the heart, kidney, lung, and liver). The diabetes management segment is expected to witness the highest growth rate during the forecast period. Growth in this segment is mainly driven by the increasing prevalence of diabetes and the rising demand for insulin pumps to manage diabetes in homecare settings.

Based on end user, homecare settings are expected to register the highest CAGR during the forecast period.

Based on end user, the APAC infusion pumps market has been segmented into hospitals, homecare settings, ambulatory care settings, and academic & research institutes. The homecare settings segment is projected to register the highest CAGR during the forecast period. Technological advancements in infusion pumps have enabled the development of compact and lightweight devices that are easy to carry and operate. This, coupled with the increasing awareness and acceptance of ambulatory infusion pumps (such as disposable pumps) at homecare settings to reduce hospital stays, propels the growth of the APAC infusion pumps market for homecare settings.

China is expected to account for the largest share of the APAC infusion pumps market in 2021
The APAC infusion pumps market is segmented into China, Japan, India, Australia, Thailand, Indonesia, Vietnam, Southeast Asia & Rest of Asia Pacific. China accounted for the largest share of the APAC infusion pumps market in 2021. The large share of China in the APAC infusion pumps market can be attributed to the increasing healthcare investment in the country.

Break of primary participants was as mentioned below:
•By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
•By Designation – C-level–30%, Director-level–50%, Others–20%
•By Country – India–45%, China–25%, Japan–25%, Southeast Asia- 10%, Others–5%

Key players in the APAC Infusion Pumps Market
The key players in the APAC infusion pumps market include are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter International, Inc. (US), Medtronic PLC (Ireland), ICU Medical, Inc. (US), Avanos Medical, Inc. (US), Terumo Corporation (Japan), Nipro Corporation (Japan), JMS Co., Ltd. (Japan), Cardinal Health, Inc. (US), Epic Medical (Singapore), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories(US), Danaher Corporation(US), Mindray Medical International Limited (China), SOOIL Development Co., Ltd. (South Korea), Micrel Medical Devices SA (Greece), Tandem Diabetes Care, Inc. (US), Ypsomed Holding AG (Switzerland), Shenzhen MedRena Biotech Co., Ltd. (China), Allied Medical Limited (India), BPL Medical Technologies (India), Shanghai LEIEN Medical Equipment Co., Ltd. (China), and Plenum Tech Pvt. Limited (India).

Research Coverage:
The report analyzes the APAC infusion pumps market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application, end user, and country. The report also includes a product portfolio matrix of various infusion pump available in the APAC market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the APAC infusion pumps market. The report analyzes this market by product, application, and end user.
•Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the APAC infusion pumps market
•Market Development: Comprehensive information on the lucrative emerging markets by product, application, and end user.
•Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the APAC infusion pumps market
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the APAC infusion pumps market.
Table of Contents

1INTRODUCTION35
1.1OBJECTIVES OF THE STUDY35
1.2MARKET DEFINITION35
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY36
1.2.2MARKETS COVERED37
FIGURE 1APAC INFUSION PUMPS MARKET SEGMENTATION37
1.2.3YEARS CONSIDERED FOR THE STUDY38
1.3CURRENCY38
1.4STAKEHOLDERS39
2RESEARCH METHODOLOGY40
2.1RESEARCH APPROACH40
FIGURE 2APAC INFUSION PUMPS MARKET: RESEARCH DESIGN40
2.1.1SECONDARY RESEARCH41
2.1.1.1Key data from secondary sources42
2.1.2PRIMARY DATA42
FIGURE 3PRIMARY SOURCES43
2.1.2.1Key data from primary sources44
2.1.2.2Key industry insights45
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION45
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE
AND DEMAND-SIDE PARTICIPANTS46
2.2MARKET SIZE ESTIMATION46
FIGURE 6SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS47
FIGURE 7REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY47
FIGURE 8DEMAND-SIDE ANALYSIS: APAC INFUSION PUMPS MARKET48
FIGURE 9TOP-DOWN APPROACH49
FIGURE 10CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE APAC INFUSION PUMPS MARKET (2022–2027)50
FIGURE 11CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS50
2.3MARKET BREAKDOWN & DATA TRIANGULATION52
FIGURE 12MARKET DATA TRIANGULATION METHODOLOGY52
2.4MARKET SHARE ANALYSIS53
2.5ASSUMPTIONS FOR THE STUDY53
2.6RISK ASSESSMENT54
TABLE 1RISK ASSESSMENT: INFUSION PUMPS MARKET54
2.7LIMITATIONS54
2.7.1METHODOLOGY-RELATED LIMITATIONS54
2.7.2SCOPE-RELATED LIMITATIONS54
3EXECUTIVE SUMMARY55
FIGURE 13APAC INFUSION PUMPS MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION)55
FIGURE 14APAC INFUSION PUMPS ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2022 VS. 2027 (USD MILLION)56
FIGURE 15APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION)56
FIGURE 16APAC INFUSION PUMPS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)57
FIGURE 17APAC INFUSION PUMPS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION)58
4PREMIUM INSIGHTS59
4.1APAC INFUSION PUMPS MARKET OVERVIEW59
FIGURE 18THE GROWING INCIDENCE OF CHRONIC DISEASES IS A KEY FACTOR DRIVING THE MARKET GROWTH59
4.2ASIA PACIFIC: INFUSION PUMPS MARKET, BY DEVICE & COUNTRY60
FIGURE 19THE VOLUMETRIC INFUSION PUMPS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 202160
4.3APAC INFUSION PUMPS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES61
FIGURE 20CHINA IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD61
4.4APAC INFUSION PUMPS MARKET, BY REGION (2020–2027)62
FIGURE 21CHINA TO DOMINATE THE APAC INFUSION PUMPS MARKET DURING THE FORECAST PERIOD62
5MARKET OVERVIEW63
5.1MARKET DYNAMICS63
FIGURE 22APAC INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES63
5.1.1MARKET DRIVERS64
5.1.1.1Rising demand for ambulatory infusion pumps in homecare settings64
5.1.1.2Rapid growth in the geriatric population and the subsequent rise in chronic diseases64
FIGURE 23ASIAN CANCER INCIDENCE, 2020–204065
FIGURE 24ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 204066
5.1.1.3Increasing adoption of enteral feeding pumps due to a surge in pre-term births67
5.1.1.4Rising number of surgical procedures performed worldwide67
5.1.1.5Increasing number of ICU beds in countries with a high prevalence of COVID-1968
TABLE 2MARKET DRIVERS: IMPACT ANALYSIS68
5.1.2MARKET RESTRAINTS69
5.1.2.1Product recalls69
TABLE 3INDICATIVE LIST OF PRODUCT RECALLS FOR INFUSION PUMPS
(2017–MARCH 2022)69
5.1.2.2Stringent regulatory requirements for the approval of new products70
5.1.2.3Increasing adoption of refurbished & rented infusion pumps70
TABLE 4MARKET RESTRAINTS: IMPACT ANALYSIS71
5.1.3MARKET OPPORTUNITIES71
5.1.3.1High growth opportunities in emerging markets71
TABLE 5RISING INCOME LEVELS IN EMERGING COUNTRIES72
5.1.3.2Growing adoption of specialty infusion systems72
TABLE 6MARKET OPPORTUNITIES: IMPACT ANALYSIS73
5.1.4MARKET CHALLENGES73
5.1.4.1Increasing incidence of medication errors and inadequate wireless connectivity in most hospitals73
TABLE 7MARKET CHALLENGES: IMPACT ANALYSIS73
5.2INDUSTRY TRENDS74
5.2.1SMART PUMP─EMR INTEROPERABILITY74
TABLE 8RECENT DEVELOPMENTS IN SMART PUMP─EMR INTEROPERABILITY74
5.2.2GROWING FOCUS ON THE DEVELOPMENT OF HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS75
TABLE 9HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO75
5.2.3GROWING FOCUS ON SPECIALTY PUMPS WITH ADDITIONAL
ADVANCED FEATURES76
5.3KEY CONFERENCES & EVENTS IN 2022-202377
TABLE 10APAC INFUSION PUMPS MARKET: DETAILED LIST OF
CONFERENCES & EVENTS77
5.4PRICING ANALYSIS77
TABLE 11ASP OF INFUSION PUMP DEVICES78
TABLE 12ASP OF NON-DEDICATED ACCESSORIES & CONSUMABLES78
5.5VALUE CHAIN ANALYSIS78
FIGURE 25APAC INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS79
5.6SUPPLY CHAIN ANALYSIS79
FIGURE 26APAC INFUSION PUMPS MARKET: SUPPLY CHAIN ANALYSIS80
5.7ECOSYSTEM MARKET MAP80
FIGURE 27INFUSION PUMPS MARKET: ECOSYSTEM MARKET MAP81
5.8PORTER’S FIVE FORCES ANALYSIS81
TABLE 13PORTER’S FIVE FORCES ANALYSIS82
5.8.1THREAT FROM NEW ENTRANTS82
5.8.2THREAT FROM SUBSTITUTES83
5.8.3BARGAINING POWER OF SUPPLIERS83
5.8.4BARGAINING POWER OF BUYERS83
5.8.5COMPETITIVE RIVALRY84
5.9REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS84
TABLE 14ASIA-PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS84
5.10REGULATORY ANALYSIS84
5.10.1APAC85
5.10.1.1Japan85
TABLE 15JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA85
5.10.1.2China85
TABLE 16CHINA: CFDA CLASSIFICATION OF MEDICAL DEVICES86
5.10.1.3India86
5.11IMPACT OF COVID-19 ON THE APAC INFUSION PUMPS MARKET87
5.12PATENT ANALYSIS88
5.12.1PATENT PUBLICATION TRENDS FOR INFUSION PUMPS88
FIGURE 28PATENT PUBLICATION TRENDS (2011–MARCH 2022)88
5.12.2INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS88
FIGURE 29TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFUSION PUMP PATENTS (JANUARY 2011–MARCH 2022)89
FIGURE 30TOP APPLICANT COUNTRIES/REGIONS FOR INFUSION PUMP PATENTS (JANUARY 2011–MARCH 2022)90
TABLE 17LIST OF PATENTS/PATENT APPLICATIONS IN THE ORGAN PRESERVATION MARKET, 2021–202290
5.13TECHNOLOGY ANALYSIS92
5.13.1KEY TECHNOLOGIES92
5.13.1.1Flow generation92
5.13.1.2Flow control92
5.13.2ADJACENT TECHNOLOGIES92
5.13.2.1Embedded software92
5.13.2.2Sensing technology93
5.13.3COMPLEMENTARY TECHNOLOGIES93
5.13.3.1Dose error reduction systems93
5.13.3.2Wireless connectivity93
5.14TRADE ANALYSIS94
TABLE 18AISA PACIFIC EXPORT DATA OF INFUSION PUMPS FOR 202094
TABLE 19TRADE DATA ANALYSIS OF INFUSION PUMP IMPORTS TO INDIA95
6APAC INFUSION PUMPS MARKET, BY PRODUCT97
6.1INTRODUCTION98
TABLE 20APAC INFUSION PUMPS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)98
6.2IMPACT OF COVID-19 ON THE APAC INFUSION PUMPS MARKET, BY PRODUCT98
6.3ACCESSORIES AND CONSUMABLES99
TABLE 21KEY INFUSION PUMP ACCESSORIES & CONSUMABLES AVAILABLE
IN THE MARKET99
TABLE 22APAC INFUSION PUMP ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2020–2027 (USD MILLION)101
TABLE 23APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY COUNTRY 2020–2027 (USD MILLION)101
6.3.1DEDICATED ACCESSORIES AND CONSUMABLES101
TABLE 24DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2020–2027 (USD MILLION)102
TABLE 25DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)102
6.3.1.1Volumetric infusion pumps103
6.3.1.1.1Increasing adoption of volumetric infusion pumps to deliver large volumes of medication and nutrients to patients in hospitals drives the market growth103
TABLE 26DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR VOLUMETRIC INFUSION PUMPS, BY COUNTRY, 2020–2027 (USD MILLION)103
6.3.1.2Insulin pumps103
6.3.1.2.1The rising demand for insulin pumps for the increasing number of insulin-dependent diabetic patients supports market growth103
TABLE 27IDF SOUTH-EAST ASIA AND WESTERN PACIFIC REGION AT A GLANCE, 2019104
TABLE 28DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR INSULIN PUMPS, BY COUNTRY, 2020–2027 (USD MILLION)104
6.3.1.3Enteral infusion pumps105
6.3.1.3.1Delivery of precise and consistent infusion results in higher adoption of enteral infusion pumps105
TABLE 29DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR ENTERAL INFUSION PUMPS, BY COUNTRY, 2020–2027 (USD MILLION)105
6.3.1.4Syringe infusion pumps106
6.3.1.4.1Adoption of dedicated syringe pump accessories is high in developed countries—a key factor driving the market growth106
TABLE 30DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR SYRINGE INFUSION PUMPS, BY REGION, 2020–2027 (USD MILLION)106
6.3.1.5Ambulatory infusion pumps107
6.3.1.5.1The growing home healthcare market fuels the adoption of dedicated ambulatory infusion pumps & accessories107
TABLE 31DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR AMBULATORY INFUSION PUMPS, BY COUNTRY, 2020–2027 (USD MILLION)107
6.3.1.6PCA pumps108
6.3.1.6.1Adoption of PCA pumps is driven by the increasing demand for pain management treatment108
TABLE 32DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR PCA PUMPS, BY COUNTRY, 2020–2027 (USD MILLION)108
6.3.1.7Implantable infusion pumps109
6.3.1.7.1Dedicated infusion pump accessories are preferred due to their compatibility with the implantable infusion pumps109
TABLE 33DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR IMPLANTABLE INFUSION PUMPS, BY COUNTRY, 2020–2027 (USD MILLION)109
6.3.2NON-DEDICATED ACCESSORIES AND CONSUMABLES110
TABLE 34NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)110
TABLE 35NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY COUNTRY 2020–2027 (USD MILLION)111
6.3.2.1Infusion catheters111
6.3.2.1.1Recurrent use of infusion catheters to drive the market growth111
TABLE 36NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR INFUSION CATHETERS, BY COUNTRY, 2020–2027 (USD MILLION)111
6.3.2.2IV/Administration sets112
6.3.2.2.1IV/administration sets are the primary requirement for infusion pumps—a key factor driving market growth112
TABLE 37NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR IV/ADMINISTRATION SETS, BY COUNTRY, 2020–2027 (USD MILLION)112
6.3.2.3Needleless connectors113
6.3.2.3.1Needleless connectors reduce bloodstream infection risks113
TABLE 38NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR NEEDLELESS CONNECTORS, BY COUNTRY 2020–2027 (USD MILLION)113
6.3.2.4Cannulas114
6.3.2.4.1Cannulas are preferred over steel needles as they do not cause discomfort to patients during body movements114
TABLE 39NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR CANNULAS, BY COUNTRY, 2020–2027 (USD MILLION)114
6.3.2.5Tubing & extension sets115
6.3.2.5.1Tubing & extension sets are used to provide a consistent connection between a patient’s body and the infusion pump115
TABLE 40NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR TUBING & EXTENSION SETS, BY COUNTRY, 2020–2027 (USD MILLION)116
6.3.2.6Valves116
6.3.2.6.1Valves are used to regulate the flow of infusion fluids116
TABLE 41NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR VALVES, BY COUNTRY, 2020–2027 (USD MILLION)117
6.3.2.7Other Non-dedicated accessories and consumables117
TABLE 42OTHER NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)118
6.4DEVICES118
6.4.1DEVICES MARKET, BY PRODUCT119
TABLE 43APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027 (USD MILLION)119
TABLE 44APAC INFUSION PUMP DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)119
6.4.1.1Volumetric infusion pumps120
6.4.1.1.1Wide range of applications for volumetric infusion pumps to drive the market growth120
TABLE 45VOLUMETRIC INFUSION PUMPS AVAILABLE IN THE MARKET120
TABLE 46APAC VOLUMETRIC INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)121
6.4.1.2Insulin pumps121
6.4.1.2.1Growing demand for smart insulin pumps and portable insulin pumps in homecare settings to drive the market growth121
TABLE 47INSULIN PUMPS AVAILABLE IN THE MARKET122
TABLE 48APAC INSULIN PUMPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)122
6.4.1.3Ambulatory infusion pumps123
TABLE 49AMBULATORY INFUSION PUMPS AVAILABLE IN THE MARKET123
TABLE 50APAC AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027 (USD MILLION)124
TABLE 51APAC AMBULATORY INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)124
6.4.1.3.1Disposable infusion pumps124
6.4.1.3.1.1Disposable infusion pumps are mainly used in homecare settings and pediatric departments124
TABLE 52DISPOSABLE INFUSION PUMPS AVAILABLE IN THE MARKET125
TABLE 53APAC DISPOSABLE INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)125
6.4.1.3.2Chemotherapy infusion pumps125
6.4.1.3.2.1These pumps administer continuous infusion to cancer patients in homecare settings125
TABLE 54CHEMOTHERAPY INFUSION PUMPS AVAILABLE IN THE MARKET126
TABLE 55APAC CHEMOTHERAPY INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)126
6.4.1.4Syringe infusion pumps126
6.4.1.4.1Syringe infusion pumps are used to deliver a lower volume of fluids at a low flow rate126
TABLE 56SYRINGE INFUSION PUMPS AVAILABLE IN THE MARKET127
TABLE 57APAC SYRINGE INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)127
6.4.1.5Enteral infusion pumps128
6.4.1.5.1Enteral infusion pumps are designed to deliver nutrients and medicines into a patient’s digestive tract128
TABLE 58ENTERAL INFUSION PUMPS AVAILABLE IN THE MARKET128
TABLE 59APAC ENTERAL INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)129
6.4.1.6PCA pumps129
6.4.1.6.1Growth in this segment is driven by the rising preference for effective pain management therapies129
TABLE 60PCA PUMPS AVAILABLE IN THE MARKET129
TABLE 61APAC PCA PUMPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)130
6.4.1.7Implantable infusion pumps130
6.4.1.7.1High costs of implantable infusion pump therapies and procedures to restrict the segment growth130
TABLE 62IMPLANTABLE INFUSION PUMPS AVAILABLE IN THE MARKET131
TABLE 63APAC IMPLANTABLE INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)131
6.4.2DEVICES MARKET, BY TECHNOLOGY131
TABLE 64APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)131
6.4.2.1Traditional infusion pumps132
6.4.2.1.1Wide applications of traditional infusion pumps due to low costs to drive the segment growth132
TABLE 65APAC TRADITIONAL INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)132
6.4.2.2Specialty infusion pumps132
6.4.2.2.1Technological advancements & the rising adoption of specialty infusion pumps in homecare settings supports segment growth132
TABLE 66APAC SPECIALTY INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)133
6.4.3DEVICES MARKET, BY TYPE133
TABLE 67APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION)133
6.4.3.1Stationary infusion pumps134
6.4.3.1.1High adoption of stationary infusion pumps in hospitals to drive the market growth134
TABLE 68APAC STATIONARY INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)134
6.4.3.2Portable infusion pumps134
6.4.3.2.1Technological advancements in portable infusion pumps to drive the growth of this segment134
TABLE 69APAC PORTABLE INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)135
7APAC INFUSION PUMPS MARKET, BY APPLICATION136
7.1INTRODUCTION137
TABLE 70APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)137
7.2CHEMOTHERAPY/ONCOLOGY138
7.2.1THE DEMAND FOR INFUSION PUMPS FOR CHEMOTHERAPY IS MAINLY DRIVEN BY THE GROWING INCIDENCE OF CANCER138
FIGURE 31ASIA PACIFIC: ESTIMATED NUMBER OF NEW CANCER CASES, BY REGION, 2020–2040138
TABLE 71APAC INFUSION PUMPS MARKET FOR CHEMOTHERAPY/ONCOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION)139
7.3DIABETES MANAGEMENT139
7.3.1THE RISING PREVALENCE OF DIABETES HAS INCREASED THE DEMAND FOR ACCESSIBLE & EFFECTIVE DIABETES MANAGEMENT—A KEY FACTOR DRIVING THE MARKET GROWTH139
FIGURE 32ASIA PACIFIC: DIABETES INCIDENCE, BY REGION, 2015–2045140
TABLE 72APAC INFUSION PUMPS MARKET FOR DIABETES MANAGEMENT,
BY COUNTRY, 2020–2027(USD MILLION)141
7.4GASTROENTEROLOGY142
7.4.1DOCTORS PREFER TREATING PATIENTS WITH SEVERE DIGESTIVE SYSTEM DISORDERS BY USING INFUSION PUMPS TO DELIVER DRUGS INTO THE SYSTEM142
TABLE 73DISEASES & DISORDERS OF THE DIGESTIVE SYSTEM142
TABLE 74APAC INFUSION PUMPS MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2020–2027(USD MILLION)143
7.5ANALGESIA/PAIN MANAGEMENT144
7.5.1THE RISING NUMBER OF SURGICAL PROCEDURES PROPEL THE MARKET GROWTH OF THIS SEGMENT144
TABLE 75ASIA PACIFIC: CHRONIC PAIN STATISTICS, 2018144
TABLE 76APAC INFUSION PUMPS MARKET FOR ANALGESIA/PAIN MANAGEMENT,
BY COUNTRY, 2020–2027(USD MILLION)145
7.6PEDIATRICS/NEONATOLOGY145
7.6.1INCREASING INCIDENCE OF PRETERM BIRTHS AND NEWBORN DEATHS DRIVE THE UPTAKE OF INFUSION PUMPS IN THIS SEGMENT145
TABLE 77ASIAN COUNTRIES WITH THE HIGHEST NUMBER OF PRETERM BIRTHS (2018)146
TABLE 78ASIAN COUNTRIES WITH THE HIGHEST NUMBER OF NEWBORN DEATHS (2020)146
TABLE 79APAC INFUSION PUMPS MARKET FOR PEDIATRICS/NEONATOLOGY,
BY COUNTRY, 2020–2027(USD MILLION)147
7.7HEMATOLOGY147
7.7.1INCREASING PREVALENCE OF BLOOD DISORDERS TO SUPPORT THE GROWTH OF THIS SEGMENT147
TABLE 80ASIA PACIFIC: PREVALENCE OF ANEMIA IN WOMEN OF REPRODUCTIVE AGE (15–49 YEARS) (% OF THE POPULATION), BY COUNTRY148
TABLE 81APAC INFUSION PUMPS MARKET FOR HEMATOLOGY, BY COUNTRY,
2020–2027(USD MILLION)148
7.8OTHER APPLICATIONS149
TABLE 82APAC INFUSION PUMPS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027(USD MILLION)149
8APAC INFUSION PUMPS MARKET, BY END USER150
8.1INTRODUCTION151
TABLE 83APAC INFUSION PUMPS MARKET, BY END USER, 2020–2027 (USD MILLION)151
8.2HOSPITALS151
8.2.1STRONG PURCHASING POWER BY HOSPITALS FOR HIGH-PRICED INFUSION PUMPS TO DRIVE THE MARKET GROWTH151
TABLE 84NUMBER OF HOSPITALS, BY COUNTRY, 2010–2020152
TABLE 85APAC INFUSION PUMPS MARKET FOR HOSPITALS, BY COUNTRY,
2020–2027 (USD MILLION)153
8.3HOMECARE SETTINGS153
8.3.1PATIENTS ARE INCREASINGLY OPTING TO GET TREATED AT HOME—
A KEY FACTOR DRIVING MARKET GROWTH153
TABLE 86APAC INFUSION PUMPS MARKET FOR HOMECARE SETTINGS, BY COUNTRY, 2020–2027(USD MILLION)154
8.4AMBULATORY CARE SETTINGS154
8.4.1GROWING NUMBER OF SURGICAL PROCEDURES PERFORMED IN ASCS TO DRIVE THE MARKET GROWTH154
TABLE 87APAC INFUSION PUMPS MARKET FOR AMBULATORY CARE SETTINGS,
BY COUNTRY, 2020–2027(USD MILLION)155
8.5ACADEMIC & RESEARCH INSTITUTES156
8.5.1INCREASING MEDICAL RESEARCH ACTIVITIES TO SUPPORT THE GROWTH OF THIS SEGMENT156
TABLE 88INFUSION PUMPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2020–2027(USD MILLION)156
9APAC INFUSION PUMPS MARKET, BY COUNTRY157
9.1INTRODUCTION158
FIGURE 33APAC: NUMBER OF CRITICAL BEDS PER 100,000 PEOPLE159
FIGURE 34ASIA PACIFIC: INFUSION PUMPS MARKET SNAPSHOT160
TABLE 89APAC INFUSION PUMPS MARKET, BY COUNTRY, 2020–2027(USD MILLION)161
9.2COVID-19 IMPACT ON THE APAC INFUSION PUMPS MARKET161
9.2.1CHINA162
9.2.1.1Growing investments in healthcare infrastructure development in China to drive the market growth162
TABLE 90KEY MACRO INDICATORS FOR CHINA163
TABLE 91CHINA: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)163
TABLE 92CHINA: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION)163
TABLE 93CHINA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)164
TABLE 94CHINA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)164
TABLE 95CHINA: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION)165
TABLE 96CHINA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION)165
TABLE 97CHINA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2020–2027(USD MILLION)165
TABLE 98CHINA: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION)166
TABLE 99CHINA: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION)166
TABLE 100CHINA: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION)166
9.2.2JAPAN167
9.2.2.1The extensive geriatric population in Japan is expected to drive the subsequent demand for infusion pumps & devices167
TABLE 101KEY MACRO INDICATORS FOR JAPAN167
TABLE 102JAPAN: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION)168
TABLE 103JAPAN: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION)168
TABLE 104JAPAN: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)168
TABLE 105JAPAN: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)169
TABLE 106JAPAN: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION)169
TABLE 107JAPAN: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION)170
TABLE 108JAPAN: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2020–2027(USD MILLION)170
TABLE 109JAPAN: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION)170
TABLE 110JAPAN: AAPC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION)171
TABLE 111JAPAN: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION)171
9.2.3INDIA171
9.2.3.1The high prevalence of lifestyle diseases drives the market growth for infusion pumps in India171
TABLE 112KEY MACRO INDICATORS FOR INDIA172
TABLE 113INDIA: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION)173
TABLE 114INDIA: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION)173
TABLE 115INDIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)173
TABLE 116INDIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)174
TABLE 117INDIA: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION)174
TABLE 118INDIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION)175
TABLE 119INDIA: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2020–2027(USD MILLION)175
TABLE 120INDIA: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION)175
TABLE 121INDIA: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION)176
TABLE 122INDIA: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION)176
9.2.4AUSTRALIA176
9.2.4.1The high prevalence of chronic diseases in the country supports the market growth176
TABLE 123KEY MACRO INDICATORS FOR AUSTRALIA177
TABLE 124AUSTRALIA: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION)177
TABLE 125AUSTRALIA: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)178
TABLE 126AUSTRALIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)178
TABLE 127AUSTRALIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION)179
TABLE 128AUSTRALIA: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION)179
TABLE 129AUSTRALIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION)180
TABLE 130AUSTRALIA: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2020–2027(USD MILLION)180
TABLE 131AUSTRALIA: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION)180
TABLE 132AUSTRALIA: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION)181
TABLE 133AUSTRALIA: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION)181
9.2.5THAILAND181
9.2.5.1The rising prevalence of cancer supports the market growth for infusion pumps in Thailand181
TABLE 134KEY MACRO INDICATORS FOR THAILAND182
TABLE 135THAILAND: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION)182
TABLE 136THAILAND: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)183
TABLE 137THAILAND: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)183
TABLE 138THAILAND: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION)184
TABLE 139THAILAND: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION)184
TABLE 140THAILAND: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION)185
TABLE 141THAILAND: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2020–2027(USD MILLION)185
TABLE 142THAILAND: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION)185
TABLE 143THAILAND: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION)186
TABLE 144THAILAND: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION)186
9.2.6INDONESIA186
9.2.6.1The rising prevalence of cancer supports the market for infusion pumps in Indonesia186
TABLE 145KEY MACRO INDICATORS FOR INDONESIA187
TABLE 146INDONESIA: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)187
TABLE 147INDONESIA: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)188
TABLE 148INDONESIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)188
TABLE 149INDONESIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027 (USD MILLION)189
TABLE 150INDONESIA: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027 (USD MILLION)189
TABLE 151INDONESIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027 (USD MILLION)190
TABLE 152INDONESIA: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)190
TABLE 153INDONESIA: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION)190
TABLE 154INDONESIA: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)191
TABLE 155INDONESIA: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027 (USD MILLION)191
9.2.7VIETNAM191
9.2.7.1The high incidence of preterm births in the country has propelled the growth of the infusion pumps market191
TABLE 156KEY MACRO INDICATORS FOR VIETNAM192
TABLE 157VIETNAM: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027 (USD MILLION)192
TABLE 158VIETNAM: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)193
TABLE 159VIETNAM: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)193
TABLE 160VIETNAM: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027 (USD MILLION)194
TABLE 161VIETNAM: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027 (USD MILLION)194
TABLE 162VIETNAM: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027 (USD MILLION)195
TABLE 163VIETNAM: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)195
TABLE 164VIETNAM: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION)195
TABLE 165VIETNAM: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)196
TABLE 166VIETNAM: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027 (USD MILLION)196
9.2.8SOUTHEAST ASIA196
9.2.8.1Growth in medical tourism in the SEA countries to drive the market for infusion pumps196
FIGURE 35PREVALENCE OF DIABETES IN SOUTHEAST ASIA, 2019197
TABLE 167ESTIMATED NUMBER OF CANCER CASES IN SOUTHEAST ASIAN COUNTRIES, 2020 VS. 2040 (IN THOUSAND)197
FIGURE 36HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2019)197
FIGURE 37GERIATRIC POPULATION IN 2020 (% OF TOTAL POPULATION)198
TABLE 168SOUTHEAST ASIA: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION)198
TABLE 169SOUTHEAST ASIA: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)198
TABLE 170SOUTHEAST ASIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION)199
TABLE 171SOUTHEAST ASIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)199
TABLE 172SOUTHEAST ASIA: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2020–2027(USD MILLION)200
TABLE 173SOUTHEAST ASIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE, 2020–2027(USD MILLION)200
TABLE 174SOUTHEAST ASIA: APAC INFUSION PUMP DEVICES MARKET,
BY TECHNOLOGY, 2020–2027(USD MILLION)200
TABLE 175SOUTHEAST ASIA: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION)201
TABLE 176SOUTHEAST ASIA: APAC INFUSION PUMPS MARKET, BY APPLICATION, 2020–2027(USD MILLION)201
TABLE 177SOUTHEAST ASIA: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION)202
9.2.9REST OF ASIA PACIFIC (ROAPAC)202
FIGURE 38ESTIMATED NUMBER OF CANCER CASES IN REST OF APAC COUNTRIES, 2020 VS. 2040 (IN THOUSAND)203
TABLE 178ROAPAC: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION)203
TABLE 179ROAPAC: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)203
TABLE 180ROAPAC: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION)204
TABLE 181ROAPAC: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION)204
TABLE 182ROAPAC: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION)205
TABLE 183ROAPAC: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION)205
TABLE 184ROAPAC: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2020–2027(USD MILLION)205
TABLE 185ROAPAC: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION)206
TABLE 186ROAPAC: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION)206
TABLE 187ROAPAC: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION)206

10COMPETITIVE LANDSCAPE207
10.1OVERVIEW207
FIGURE 39KEY PLAYER STRATEGIES208
10.2REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS209
FIGURE 40REVENUE ANALYSIS OF THE TOP PLAYERS IN THE APAC INFUSION PUMPS MARKET209
10.3MARKET SHARE ANALYSIS210
FIGURE 41APAC INFUSION PUMPS MARKET SHARE BY KEY PLAYER, 2021210
TABLE 188APAC INFUSION PUMPS MARKET: DEGREE OF COMPETITION211
10.4COMPANY EVALUATION QUADRANT213
10.4.1STARS213
10.4.2EMERGING LEADERS213
10.4.3PERVASIVE PLAYERS213
10.4.4PARTICIPANTS213
FIGURE 42INFUSION PUMPS MARKET: COMPANY EVALUATION QUADRANT (2021)214
10.5COMPANY FOOTPRINTS215
TABLE 189FOOTPRINT OF COMPANIES IN THE APAC INFUSION PUMPS MARKET215
TABLE 190PRODUCT PORTFOLIO ANALYSIS: APAC INFUSION PUMPS MARKET216
TABLE 191APPLICATION PORTFOLIO ANALYSIS: APAC INFUSION PUMPS MARKET218
TABLE 192END USER PORTFOLIO ANALYSIS: APAC INFUSION PUMPS MARKET219
10.6COMPETITIVE SCENARIO220
10.6.1PRODUCT LAUNCHES220
TABLE 193PRODUCT LAUNCHES (JANUARY 2018 – FEBRUARY 2022)220
10.6.2DEALS221
TABLE 194DEALS (JANUARY 2018–FEBRUARY 2022)221
10.6.3OTHER DEVELOPMENTS222
TABLE 195OTHER DEVELOPMENTS (JANUARY 2018– FEBRUARY 2022)222

Report Title: APAC Infusion Pumps Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)), Technology (Traditional, Specialty), Application (Cancer, Diabetes), & End User (Hospital, Home Care) - Fore cast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline